Polypharmacy in Heart Failure: Progress But Also Problem
- PMID: 34051153
- PMCID: PMC10326723
- DOI: 10.1016/j.amjmed.2021.05.007
Polypharmacy in Heart Failure: Progress But Also Problem
Conflict of interest statement
Figures
Comment on
-
Polypharmacy in Heart Failure with Reduced Ejection Fraction: Progress, Not Problem.Am J Med. 2021 Sep;134(9):1068-1070. doi: 10.1016/j.amjmed.2021.03.038. Epub 2021 May 1. Am J Med. 2021. PMID: 33939999 Free PMC article. No abstract available.
Similar articles
-
Polypharmacy in Heart Failure with Reduced Ejection Fraction: Progress, Not Problem.Am J Med. 2021 Sep;134(9):1068-1070. doi: 10.1016/j.amjmed.2021.03.038. Epub 2021 May 1. Am J Med. 2021. PMID: 33939999 Free PMC article. No abstract available.
-
The problem of polypharmacy in heart failure.Curr Cardiol Rep. 2006 May;8(3):217-25. doi: 10.1007/s11886-006-0037-7. Curr Cardiol Rep. 2006. PMID: 17543249 Review.
-
Polypharmacy (or polytherapy) in the treatment of heart failure.Heart Fail Monit. 2000;1(1):8-13. Heart Fail Monit. 2000. PMID: 12634876 Review.
-
Evidence-Based Prescribing and Polypharmacy for Patients With Heart Failure.Ann Intern Med. 2021 Aug;174(8):1165-1166. doi: 10.7326/M21-1427. Epub 2021 Jun 29. Ann Intern Med. 2021. PMID: 34181442 No abstract available.
-
Specialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and drug-interactions.Eur J Heart Fail. 2004 Mar 1;6(2):235-43. doi: 10.1016/j.ejheart.2003.08.003. Eur J Heart Fail. 2004. PMID: 14984732
Cited by
-
Polypharmacy in Older Heart Failure Patients: a Multidisciplinary Approach.Curr Heart Fail Rep. 2022 Oct;19(5):290-302. doi: 10.1007/s11897-022-00559-w. Epub 2022 Jun 20. Curr Heart Fail Rep. 2022. PMID: 35723783 Review.
-
Geriatric Domains in Patients with Heart Failure with Preserved Ejection Fraction.Cardiol Clin. 2022 Nov;40(4):517-532. doi: 10.1016/j.ccl.2022.06.006. Epub 2022 Sep 5. Cardiol Clin. 2022. PMID: 36210135 Free PMC article. Review.
-
Hyperpolypharmacy is a predictor of mortality after left ventricular assist device (LVAD) implantation.Am Heart J Plus. 2022 Dec 5;24:100233. doi: 10.1016/j.ahjo.2022.100233. eCollection 2022 Dec. Am Heart J Plus. 2022. PMID: 38560633 Free PMC article.
-
Glycnsisitin A: A promising bicyclic peptide against heart failure that facilitates TFRC-mediated uptake of iron in cardiomyocytes.Acta Pharm Sin B. 2024 Jul;14(7):3125-3139. doi: 10.1016/j.apsb.2024.02.026. Epub 2024 Mar 3. Acta Pharm Sin B. 2024. PMID: 39027250 Free PMC article.
-
The effect of down-titration and discontinuation of heart failure pharmacotherapy in older people: A systematic review and meta-analysis.Br J Clin Pharmacol. 2025 Jan;91(1):23-37. doi: 10.1111/bcp.16223. Epub 2024 Sep 16. Br J Clin Pharmacol. 2025. PMID: 39285726 Free PMC article.
References
-
- Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol 2017;70(6):776–803. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical